OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neurology is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
The deltoid muscle and the pattern of paresis in ALS	198
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	191
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	164
Tacrolimus-induced Parkinsonism	135
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	97
The DeMyers: Marian (1922–2012) and William (1924–2008)	89
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	87
Richard Caton (1842-1926)	86
A role for the Epstein–Barr virus in multiple sclerosis aetiology?	78
Tourette syndrome: effects of acetyl-leucine in two individuals	78
Complications of reversible cerebral vasoconstriction syndrome in relation to age	77
Dizziness and spatial disorientation in patients with transient global amnesia: clinical and vestibular correlates	75
Dystonia management across Europe within ERN-RND: current state and future challenges	74
Recent applications of quantitative electroencephalography in adult intensive care units: a comprehensive review	73
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	73
Explaining recovery from coma with multimodal neuroimaging	70
Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity	70
A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder	65
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	63
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	62
International survey on the implementation of the European and American guidelines on disorders of consciousness	62
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study	61
Cross-sectional brain volumetric measures and disability outcomes in relapsing–remitting multiple sclerosis	60
A decision aid is not the quick fix for improving shared decision-making in advanced Parkinson’s disease: results of a mixed methods feasibility study	57
Neurological manifestation of HEV infection: still a rare disease entity?	57

Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis	56
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension	56
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	55
Disrupted and reorganized connectivity of brain networks in multiple sclerosis: a systematic review and meta-analysis of resting-state functional MRI	54
Primary progressive aphasia: six questions in search of an answer	54
Restless legs syndrome in Parkinson’s disease: epidemiology, pathogenetic overlaps, and clinical management	53
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	50
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	50
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies	49
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	49
Hashimoto’s encephalopathy with diffuse leukoencephalopathy: serial MRI and gait analysis	49
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis	48
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	47
Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?	46
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	45
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	45
Nomograms integrating cortical morphometric metrics with 3D multi-parametric MRI radiomics for predicting disability progression and cognitive worsening in relapsing–remitting multiple sclerosis: a mu	45
Performance of blind source separation in localizing seizure onset from routine scalp-EEG	45
Improving conscientiousness through a smartphone app and telecoaching intervention: insights from multiple sclerosis and healthy aging samples	45
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	44
Perceptual response characterization in acute vestibular implant stimulation	44
A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution	44
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	44
Comprehensive effects of Parkinson’s disease multimodal complex treatment (PD-MCT): a two-center prospective trial	44